Abstract: The present invention relates to pharmaceutical composition comprising combination of Lifitegrast and Loteprednol etabonate along with one or more pharmaceutically acceptable excipients for the treatment of dry eye disease.
| # | Name | Date |
|---|---|---|
| 1 | 202447066790-REQUEST FOR EXAMINATION (FORM-18) [04-09-2024(online)].pdf | 2024-09-04 |
| 2 | 202447066790-POWER OF AUTHORITY [04-09-2024(online)].pdf | 2024-09-04 |
| 3 | 202447066790-FORM 18 [04-09-2024(online)].pdf | 2024-09-04 |
| 4 | 202447066790-FORM 1 [04-09-2024(online)].pdf | 2024-09-04 |
| 5 | 202447066790-DECLARATION OF INVENTORSHIP (FORM 5) [04-09-2024(online)].pdf | 2024-09-04 |
| 6 | 202447066790-COMPLETE SPECIFICATION [04-09-2024(online)].pdf | 2024-09-04 |